United States securities and exchange commission logo February 8, 2023 Eddie Sullivan, Ph.D. President and Chief Executive Officer SAB Biotherapeutics, Inc. 2100 East 54th Street North Sioux Falls, SD 57104 Re: SAB Biotherapeutics, Inc. Registration Statement on Form S-3 Filed February 3, 2023 File No. 333-269565 Dear Eddie Sullivan: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Ilan Katz